We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Quidel (QDEL - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of QDEL and the rest of the Medical group's stocks.
Quidel is a member of our Medical group, which includes 890 different companies and currently sits at #1 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. QDEL is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for QDEL's full-year earnings has moved 1.15% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, QDEL has returned 143.26% so far this year. Meanwhile, the Medical sector has returned an average of -3.22% on a year-to-date basis. As we can see, Quidel is performing better than its sector in the calendar year.
Looking more specifically, QDEL belongs to the Medical - Products industry, which includes 81 individual stocks and currently sits at #67 in the Zacks Industry Rank. Stocks in this group have lost about 6.20% so far this year, so QDEL is performing better this group in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to QDEL as it looks to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Quidel (QDEL - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of QDEL and the rest of the Medical group's stocks.
Quidel is a member of our Medical group, which includes 890 different companies and currently sits at #1 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. QDEL is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for QDEL's full-year earnings has moved 1.15% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, QDEL has returned 143.26% so far this year. Meanwhile, the Medical sector has returned an average of -3.22% on a year-to-date basis. As we can see, Quidel is performing better than its sector in the calendar year.
Looking more specifically, QDEL belongs to the Medical - Products industry, which includes 81 individual stocks and currently sits at #67 in the Zacks Industry Rank. Stocks in this group have lost about 6.20% so far this year, so QDEL is performing better this group in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to QDEL as it looks to continue its solid performance.